FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2936688313> ?p ?o ?g. }

• W2936688313 endingPage "1571" @default.
• W2936688313 startingPage "1555" @default.
• W2936688313 abstract "The T790M mutation is recognized as a typical mechanism of acquired resistance to first generation of epithermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib in non-small cell lung cancer (NSCLC) patients who are commonly treated by third generation of EGFR-TKI AZD9291 (osimertinib). However, the therapeutic strategy for overcoming acquired resistance to EGFR-TKIs in NSCLC patients without T790M remains to be definitively determined. In the present study, gefitinib-resistant H1650 (H1650GR) or AZD9291-resistant H1975 (H1975AR) was generated by exposing NSCLC cell line H1650 or H1975 to progressively increased concentrations of gefitinib or AZD9291 over 11 months. The cytotoxic effects of gefitinib or AZD9291 in vitro were evaluated via the half maximal inhibitory concentrations (IC50s) determined by the MTT assay. IC50 of gefitinib in H1650GR (50.0 ± 3.0 µM) significantly increased compared with H1650 (31.0 ± 1.0 µM) (p < 0.05). Similarly, the IC50 of AZD9291 in H1975AR (10.3 ± 0.9 µM) significantly increased compared with H1975 (5.5 ± 0.6 µM) (p < 0.05). However, IC50 of AZD9291 on H1650GR (8.5 ± 0.5 µM) did not increase compared with H1650 (9.7 ± 0.7 µM). On the other hand, IC50 of AZD9291 on gefitinib-resistant A549 (A549GR established in our previous study) (12.7 ± 0.8 µM) was significantly increased compared with A549 (7.0 ± 1.0 µM) (p < 0.05). AZD9291 induced caspase 3/7 activation in A549, H1650, and H1650GR, but not in A549GR. Western blot analyses showed that p-Akt played a key role in determining the sensitivities of A549, A549GR, H1650, and H1650GR to gefitinib or AZD9291. Additionally, increased expression of Twist1 was observed in all cells with acquired EGFR-TKI resistance and knockdown of Twist1 by shRNA was found to significantly enhance the sensitivity of A549GR to gefitinib or AZD9291 via reversing epithelial-mesenchymal transition and downregulating p-Akt, but not of H1975AR to AZD9291. The enhanced cytotoxic effect of AZD9291 on A549GR by Twist1 knockdown in vitro was further validated by in vivo studies which showed that Twist1 knockdown could lead to significantly delayed tumor growth of A549GR xenograft with increased sensitivity to AZD9291 treatment in nude mice without any observed side toxic effects. In summary, our study demonstrated that the mechanisms of acquired resistance in different NSCLC cell lines treated by even the same EGFR-TKI might be quite different, which provide a rationale for adopting different therapeutic strategies for those NSCLC patients with acquired EGFR-TKI resistance based on different status of heterogeneous mutations." @default.
• W2936688313 created "2019-04-25" @default.
• W2936688313 creator A5073408436 @default.
• W2936688313 creator A5082797513 @default.
• W2936688313 date "2019-04-16" @default.
• W2936688313 modified "2023-10-16" @default.
• W2936688313 title "Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo" @default.
• W2936688313 cites W1489240871 @default.
• W2936688313 cites W1525382936 @default.
• W2936688313 cites W1546552389 @default.
• W2936688313 cites W1849856438 @default.
• W2936688313 cites W1976913465 @default.
• W2936688313 cites W1981984417 @default.
• W2936688313 cites W1982890204 @default.
• W2936688313 cites W1987283660 @default.
• W2936688313 cites W1988418033 @default.
• W2936688313 cites W1992089244 @default.
• W2936688313 cites W1995720102 @default.
• W2936688313 cites W2008596564 @default.
• W2936688313 cites W2011684274 @default.
• W2936688313 cites W2020608820 @default.
• W2936688313 cites W2028972576 @default.
• W2936688313 cites W2032075832 @default.
• W2936688313 cites W2063407256 @default.
• W2936688313 cites W2070241543 @default.
• W2936688313 cites W2083798214 @default.
• W2936688313 cites W2088540000 @default.
• W2936688313 cites W2090576862 @default.
• W2936688313 cites W2098920385 @default.
• W2936688313 cites W2103265885 @default.
• W2936688313 cites W2104837386 @default.
• W2936688313 cites W2106391833 @default.
• W2936688313 cites W2118004874 @default.
• W2936688313 cites W2118320591 @default.
• W2936688313 cites W2125689880 @default.
• W2936688313 cites W2129656399 @default.
• W2936688313 cites W2131549226 @default.
• W2936688313 cites W2136601558 @default.
• W2936688313 cites W2140838553 @default.
• W2936688313 cites W2141903666 @default.
• W2936688313 cites W2143913849 @default.
• W2936688313 cites W2146983373 @default.
• W2936688313 cites W2152965684 @default.
• W2936688313 cites W2155383844 @default.
• W2936688313 cites W2160138651 @default.
• W2936688313 cites W2169816570 @default.
• W2936688313 cites W2233032895 @default.
• W2936688313 cites W2302518824 @default.
• W2936688313 cites W2410679385 @default.
• W2936688313 cites W241310830 @default.
• W2936688313 cites W2462969936 @default.
• W2936688313 cites W2519926726 @default.
• W2936688313 cites W2529614871 @default.
• W2936688313 cites W2547499110 @default.
• W2936688313 cites W2551592805 @default.
• W2936688313 cites W2565210690 @default.
• W2936688313 cites W2577661161 @default.
• W2936688313 cites W2586389739 @default.
• W2936688313 cites W2600066980 @default.
• W2936688313 cites W2604550103 @default.
• W2936688313 cites W2734470318 @default.
• W2936688313 cites W2737761667 @default.
• W2936688313 cites W2750972785 @default.
• W2936688313 cites W2752048759 @default.
• W2936688313 cites W2760440513 @default.
• W2936688313 cites W2783540671 @default.
• W2936688313 cites W2795708883 @default.
• W2936688313 cites W2889423013 @default.
• W2936688313 cites W950232622 @default.
• W2936688313 doi "https://doi.org/10.1007/s00204-019-02453-2" @default.
• W2936688313 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6625885" @default.
• W2936688313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30993382" @default.
• W2936688313 hasPublicationYear "2019" @default.
• W2936688313 type Work @default.
• W2936688313 sameAs 2936688313 @default.
• W2936688313 citedByCount "19" @default.
• W2936688313 countsByYear W29366883132020 @default.
• W2936688313 countsByYear W29366883132021 @default.
• W2936688313 countsByYear W29366883132022 @default.
• W2936688313 countsByYear W29366883132023 @default.
• W2936688313 crossrefType "journal-article" @default.
• W2936688313 hasAuthorship W2936688313A5073408436 @default.
• W2936688313 hasAuthorship W2936688313A5082797513 @default.
• W2936688313 hasBestOaLocation W29366883132 @default.
• W2936688313 hasConcept C121608353 @default.
• W2936688313 hasConcept C126322002 @default.
• W2936688313 hasConcept C143998085 @default.
• W2936688313 hasConcept C153911025 @default.
• W2936688313 hasConcept C173396325 @default.
• W2936688313 hasConcept C185592680 @default.
• W2936688313 hasConcept C202751555 @default.
• W2936688313 hasConcept C207001950 @default.
• W2936688313 hasConcept C2776256026 @default.
• W2936688313 hasConcept C2777626846 @default.
• W2936688313 hasConcept C2777752497 @default.
• W2936688313 hasConcept C2777930144 @default.
• W2936688313 hasConcept C2778087573 @default.
• W2936688313 hasConcept C2779438470 @default.

• next